These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

196 related articles for article (PubMed ID: 36685583)

  • 1. The relevance between hypoxia-dependent spatial transcriptomics and the prognosis and efficacy of immunotherapy in claudin-low breast cancer.
    Sun H; Li Y; Zhang Y; Zhao X; Dong X; Guo Y; Mo J; Che N; Ban X; Li F; Bai X; Li Y; Hao J; Zhang D
    Front Immunol; 2022; 13():1042835. PubMed ID: 36685583
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Neuropilin-1 is over-expressed in claudin-low breast cancer and promotes tumor progression through acquisition of stem cell characteristics and RAS/MAPK pathway activation.
    Tang YH; Rockstroh A; Sokolowski KA; Lynam LR; Lehman M; Thompson EW; Gregory PA; Nelson CC; Volpert M; Hollier BG
    Breast Cancer Res; 2022 Jan; 24(1):8. PubMed ID: 35078508
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Claudins as prognostic factors of breast cancer].
    Szász MA
    Magy Onkol; 2012 Sep; 56(3):209-12. PubMed ID: 23139925
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A novel hypoxia- and lactate metabolism-related signature to predict prognosis and immunotherapy responses for breast cancer by integrating machine learning and bioinformatic analyses.
    Li J; Qiao H; Wu F; Sun S; Feng C; Li C; Yan W; Lv W; Wu H; Liu M; Chen X; Liu X; Wang W; Cai Y; Zhang Y; Zhou Z; Zhang Y; Zhang S
    Front Immunol; 2022; 13():998140. PubMed ID: 36275774
    [TBL] [Abstract][Full Text] [Related]  

  • 5. High
    Onaga C; Tamori S; Motomura H; Ozaki A; Matsuda C; Matsuoka I; Fujita T; Nozaki Y; Hara Y; Kawano Y; Harada Y; Sato T; Mano Y; Sato K; Akimoto K
    Anticancer Res; 2021 Jan; 41(1):43-54. PubMed ID: 33419798
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Identification of Hypoxia-Related Subtypes, Establishment of Prognostic Models, and Characteristics of Tumor Microenvironment Infiltration in Colon Cancer.
    Wang C; Tang Y; Ma H; Wei S; Hu X; Zhao L; Wang G
    Front Genet; 2022; 13():919389. PubMed ID: 35783281
    [No Abstract]   [Full Text] [Related]  

  • 7. Hypoxic microenvironment induced spatial transcriptome changes in pancreatic cancer.
    Sun H; Zhang D; Huang C; Guo Y; Yang Z; Yao N; Dong X; Cheng R; Zhao N; Meng J; Sun B; Hao J
    Cancer Biol Med; 2021 Jun; 18(2):616-30. PubMed ID: 34086429
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Oncogenic signaling pathway-related long non-coding RNAs for predicting prognosis and immunotherapy response in breast cancer.
    Li H; Liu H; Hao Q; Liu X; Yao Y; Cao M
    Front Immunol; 2022; 13():891175. PubMed ID: 35990668
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Hypoxic Characteristic in the Immunosuppressive Microenvironment of Hepatocellular Carcinoma.
    Mo Z; Liu D; Rong D; Zhang S
    Front Immunol; 2021; 12():611058. PubMed ID: 33679749
    [No Abstract]   [Full Text] [Related]  

  • 10. Intratumor heterogeneity of breast cancer detected by epialleles shows association with hypoxic microenvironment.
    Wang Y; Zhang Y; Huang Y; Chen C; Zhang X; Xing Y; Gu Y; Zhang M; Cai L; Xu S; Sun B
    Theranostics; 2021; 11(9):4403-4420. PubMed ID: 33754068
    [No Abstract]   [Full Text] [Related]  

  • 11. Development of a novel prognostic signature based on single-cell combined bulk RNA analysis in breast cancer.
    Xiao Y; Hu G; Xie N; Yin L; Pan Y; Liu C; Lou S; Zhu C
    J Gene Med; 2024 Feb; 26(2):e3673. PubMed ID: 38404059
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Comprehensive analysis of 33 human cancers reveals clinical implications and immunotherapeutic value of the solute carrier family 35 member A2.
    Xu S; Chen X; Fang J; Chu H; Fang S; Zeng L; Ma H; Zhang T; Chen Y; Wang T; Zhang X; Shen T; Zheng Y; Xu D; Lu Z; Pan Y; Liu Y
    Front Immunol; 2023; 14():1155182. PubMed ID: 37275857
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Regulatory T cells are associated with the tumor immune microenvironment and immunotherapy response in triple-negative breast cancer.
    Huang P; Zhou X; Zheng M; Yu Y; Jin G; Zhang S
    Front Immunol; 2023; 14():1263537. PubMed ID: 37767092
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Establishment and validation of an aging-related risk signature associated with prognosis and tumor immune microenvironment in breast cancer.
    Wang Z; Liu H; Gong Y; Cheng Y
    Eur J Med Res; 2022 Dec; 27(1):317. PubMed ID: 36581948
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Tumor immune microenvironment-based clusters in predicting prognosis and guiding immunotherapy in breast cancer.
    Liu Y; He X; Yang YI
    J Biosci; 2024; 49():. PubMed ID: 38287674
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Characterization of Exosome-Related Gene Risk Model to Evaluate the Tumor Immune Microenvironment and Predict Prognosis in Triple-Negative Breast Cancer.
    Qiu P; Guo Q; Yao Q; Chen J; Lin J
    Front Immunol; 2021; 12():736030. PubMed ID: 34659224
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Identification of inhibitory immune checkpoints and relevant regulatory pathways in breast cancer stem cells.
    Shi H; Yang Y
    Cancer Med; 2021 Jun; 10(11):3794-3807. PubMed ID: 33932112
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Spatial Transcriptomics Reveal Pitfalls and Opportunities for the Detection of Rare High-Plasticity Breast Cancer Subtypes.
    Coutant A; Cockenpot V; Muller L; Degletagne C; Pommier R; Tonon L; Ardin M; Michallet MC; Caux C; Laurent M; Morel AP; Saintigny P; Puisieux A; Ouzounova M; Martinez P
    Lab Invest; 2023 Dec; 103(12):100258. PubMed ID: 37813278
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Gene expression in extratumoral microenvironment predicts clinical outcome in breast cancer patients.
    Román-Pérez E; Casbas-Hernández P; Pirone JR; Rein J; Carey LA; Lubet RA; Mani SA; Amos KD; Troester MA
    Breast Cancer Res; 2012 Mar; 14(2):R51. PubMed ID: 22429463
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Comprehensive analysis of nicotinamide metabolism-related signature for predicting prognosis and immunotherapy response in breast cancer.
    Cui H; Ren X; Dai L; Chang L; Liu D; Zhai Z; Kang H; Ma X
    Front Immunol; 2023; 14():1145552. PubMed ID: 36969219
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.